Xiang Yang, Guo Jing, Peng You-Fan, Huang Hua-Tuo, Lan Yan, Wei Ye-Sheng
Department of Clinical Laboratory, The Affiliated Hospital of Youjiang Medical University for Nationalities, 533000, Baise, Guangxi, China.
Department of Dermatology, the Affiliated Hospital of Youjiang Medical University for Nationalities, 533000, Baise, Guangxi, China.
Rheumatol Int. 2017 Aug;37(8):1287-1294. doi: 10.1007/s00296-017-3745-y. Epub 2017 May 26.
The aim of this study was to investigate the association of three polymorphisms of CD154 with risk of SLE in Chinese population. The study population comprised 770 Chinese individuals, including 350 SLE patients and 420 healthy controls. The gene polymorphism was measured using Snapshot SNP genotyping assays and confirmed by sequencing. Serum CD154 (sCD154) level was measured by ELISA. Compared with control group, sCD154 levels were significantly increased in case group (P < 0.001). The minor C allele of rs1126535 was associated with a significantly increased risk of SLE as compared to the major T allele (P < 0.001). Furthermore, an increased frequency of C-G-A haplotype was also detected in case group which associated with an increased risk of SLE (P = 0.009). Notably, patients carrying rs1126535CT/CC genotypes had a higher sCD154 level compared with that carrying rs1126535TT genotype (P < 0.05). Unfortunately, analyses on the association between rs1126535 and several clinical manifestations of SLE failed to find any significant results. In conclusion, these results indicated that CD154 gene polymorphisms may associate with the risk of SLE and may play regulation role in the expression of sCD154 in SLE patients.
本研究旨在探讨CD154基因的三种多态性与中国人群系统性红斑狼疮(SLE)发病风险之间的关联。研究对象包括770名中国人,其中350例SLE患者和420名健康对照者。采用Snapshot SNP基因分型检测法对基因多态性进行检测,并通过测序进行验证。采用酶联免疫吸附测定法(ELISA)检测血清CD154(sCD154)水平。与对照组相比,病例组sCD154水平显著升高(P<0.001)。与主要的T等位基因相比,rs1126535的次要C等位基因与SLE发病风险显著增加相关(P<0.001)。此外,在病例组中还检测到C-G-A单倍型频率增加,其与SLE发病风险增加相关(P=0.009)。值得注意的是,携带rs1126535 CT/CC基因型的患者sCD154水平高于携带rs1126535 TT基因型的患者(P<0.05)。遗憾的是,对rs1126535与SLE几种临床表现之间的关联分析未发现任何显著结果。总之,这些结果表明,CD154基因多态性可能与SLE发病风险相关,并可能在SLE患者sCD154表达中发挥调节作用。